boston recoveri view align model outpati
skew rel emerg mix fuel confid
boston attract phase recoveri stori pt
quarter line high level top line guidanc earlier
month boston report revenu vs mse organ
growth vs mse busi segment line slightli
estim cardiovascular revenu vs mse
rhythm neuro vs mse medsurg vs
mse see exhibit segment-level varianc ep less relev given
acut shortfal margin larg line gross margin
vs mse oper margin vs mse look
normal analysi lay exhibit ep neuromod urolog
women deviat peer averag within coverag
assum ep portfolio reposit issu impact
dynam procedur exhibit normalci
exhibit fall elect categori make sens
underli basi analysi
taken licens work back guidanc
manag provid back februari ex china impact assum
china hit remain busi scale back origin
estim last week march consist peer analys would
suggest organ revenu declin versu declin post
impli compani could trend toward higher end
guidanc underli basi support manag commentari
thing track prior impact
thought recoveri commentari around procedur recoveri trajectori
consist mse hit hardest vs organ
mse show sequenti recoveri still y/i vs organ mse
return posit growth vs organ mse fact
boston recoveri commentari less aggress edward
influenc us appear prudent risk-adjust comment
recaptur definit still believ primari mitig
procedur recaptur impact patient referr channel
resurg resurg prepared could impact hospit
flu season later year emerg inpati vs outpati mix
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
disclosur modestli better prior assumpt aid boston
recoveri curv key procedur area includ neuromodul
urolog pelvic health endoscopi
organ growth stay around
term spend commentari suggest overal spend variabl
scale back remain opex fix
essenti move total opex revenu north
month april impli neg ebit month
trough revenu earn improv prior model
alreadi account type drop modestli
lower number ebit ep
strateg chang boston share perform sinc
februari peak yesterday close surpris rang
consid boston
leverag lack insul offset well phase recoveri model
surpris coupl area remain focu
total compris revolv capac
cash hand address coven overhang
summar releas last week see
control boston reduc work week product adjust
focu compani plenti capac serv
normalci assumpt well potenti recaptur surg
bull case long-term invest unlik impact besid clinic
new product pipelin worth consid af cryo
balloon polarx exalt-d lesser extent continu lotu
roll-out train market develop need occur
unlik happen extent plan especi around
product reli in-person train trajectori well revenu
contribut impact said go issu
product launch
women health divestitur small sale believ
strateg action made last year evidenc boston desir
back channel medsystem deal compani remain
focus urolog busi cytuiti like deriv victim
look ahead thought still bit earli assum
revenu recoveri rel level ep
coverag compar boston respect
detail around revenu prospect remain outstand manag
seem optimist abil match earn sale
limit linger effect fear true would sourc
upsid estim
group coverag three phase phase includ supplier
phase includ discretionari implant capit intens busi
given emerg element within mani busi line continu
see boston one attract phase recoveri stori come
outsid framework favor view boston continu
rest solid triple-threat thesi base above-p organ growth
continu room margin expans flexibl balanc sheet
deploy underpin overweight rate maintain pt
base ep repres premium larg cap peer set
price-to-earnings given boston attract growth margin expans prospect
leverag profil line high growth peer abbott
peer top bottom line growth drive posit risk-reward
price target base multipl base case ep
assum trade premium larg cap peer justi superior emerg
growth margin expans opportun leverag prole
matur pipelin augment
drive sustain hsd organ growth
prole bp annual margin
expans drive mid teen ep growth
support premium valuat peer
organ revenu growth
sustain boston shift
faster end market share gain
continu wamgr shift today
margin expans driven
integr oper efcienc
balanc sheet exibl improv
thomson reuter morgan stanley research morgan stanley institut equiti divis probabl
bull base bear case scenario play estim impli volatil data option market
apr gure approxim risk-neutr probabl stock reach beyond scenario price
either three-month one-year time view explan option probabl methodolog
impact mute organ
growth acceler doubl digiti
pipelin program outperform
sale inect faster expect high
increment protabl new growth
driver better leverag recent
acceler margin expans drive
high teen greater ep growth
impact prove pronounc
elect durabl procedur
follow acut recoveri
sustain execut support
growth stori recent build
pipelin program drive above-p
compound-annual-growth-rate oper margin remain track
bp annual improv
next sever year drive mid-teen ep
view descript risk reward theme
pressur multipl front
less accret organ growth key
pipelin product fail come market
tavr fail gain traction stent
price share pressur increas
weigh organ growth requir
pipelin focus expand
higher growth end market wamgr move
long term margin expans target
beyond suggest plenti room
china india
view explan region hierarchi
research highest favor quintil
less meaning expect
product ramp faster expect
share gain pronounc
achiev lotu expans
increas competit core de
market competit product launch
failur execut plan pipelin
program integr
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
million except ep
million
million
million
exhibit report segment revenu mse
sale
sale
sale
sale
good sold
plant properti equip net
sale busi
depreci amort
net chang work capit
oper
payment acquisit
proce busi divestitur
payment invest acquisit certain
proce invest collect note receiv
invest
payment conting consider amount
chang long-term debt
chang short-term debt
payment acquisit treasuri stock
use net share settl employe equiti
proce issuanc share common stock
financ
effect foreign exchang rate cash
balanc begin period
balanc end period
